Genomic epidemiologist & translational scientist in cardio-oncology at the Montreal Heart Institute. @DanaFarber alumni + Sports enthusiast.
Joined February 2011
- Tweets2.3K
- Following214
- Followers1.9K
- Likes9.4K
This is very well-deserved. Vincent worked rigorously, continuously, and collaboratively to test his hypothesis which has now captured everyone's attention. Bravo! 👏👏
🌟 Congratulations @VincentWenxinXu who will receive the KCA's Christopher G. Wood Rising Star Award at #IKCSNA26 in November! This award recognizes talented and promising #kidneycancer experts. Read more: kidneycancer.org/2026-ikcsna…
Maxine Sun retweeted
Love that the @KidneyCancer #WomeninRCC program brings together a group coaching cohort every year! Thanks @GEVaughan1 for spearheading!
Please consider applying!
@hannahdzmd @jackiebrown_MD @CharleneMantia @bergsa83 @ERPlimackMD @DrVaishampayan
🙌 Apply for KCA's #WomenInRCC leadership coaching course!
Apply through 10/2 🔗 kidneycancer.org/coaching/
Get invaluable support to navigate your career in series of virtual group sessions, led by expert coach Sioux Thompson of @ChangeFusion.
Maxine Sun retweeted
1/5 New in @UrolOncol: consensus statements from the IKCS North America 2025 Think Tank on trials for rare kidney cancers. 46 experts. 20 statements. One message: move beyond pooled “non-clear cell” #kidneycancer primary analyses: authors.elsevier.com/a/1nmZc…
Maxine Sun retweeted
TAMs get blamed for immune evasion in kidney cancer. Here, more of them trended with a better response to first-line nivolumab.
🔬 HCRN GU16-260, tested first-line nivolumab monotherapy with salvage ipi in metastatic ccRCC n=72 ccRCC:
🎯 CD163+ TAM density, OR 2.21, PFS HR 0.77
🎯 Nonexhausted CD8+ TILs: OR 1.54, PFS HR 0.79. 🎯TLS density moved the same way, PFS HR 0.92
⚠️ PD-1+ Tregs ran opposite: high fraction, PFS 3.4 vs 10.9 months
🔍 Combined, they split outcomes better than alone. Hypothesis-generating, not a validated assay continues to argue for multi-marker panels in future trials.
👉 bit.ly/ElAhmar-HCRN-TME-Biom…
Emphasis on amazing team work and learning from every patient about biology on every trial. Huge effort: @hoosiercancer @Nourhanelahmar @DrChoueiri @HHammersMD @NaomiHaas5 #MikeAtkins @BraunMDPhD #CatherineWu @maxinesun @LabSignoretti ! Many others
#KidneyCancer #RCC #Immunotherapy #GUonc
Maxine Sun retweeted
Our new paper is out in JAMA, led by our fellow Andrea Cosenza: focal therapy for prostate cancer remains uncommon nationally, but half of the procedures performed were in patients whose disease was either too low-risk to need treatment, or too high-risk for focal therapy to be the appropriate choice.
Focal therapy has real promise. My partners and I at @UPMC @UPMCUrology believe in it. But promise isn't the same as "right for every patient." That distinction matters more as our treatment options keep growing. @DavidDan_Ngn @JasonZhiyuQian @ruimmbernardino @Putnam_Cole @daviesbj @GGandaglia – at Pittsburgh, PA
From NCDB, @qdtrinh @daviesbj @Putnam_Cole et al showed AS/WW is up to 80%! They raise alarms re: focal tx use patterns—this should not be done for low-risk, but NCCN risk groups are not the right way to determine whether focal is appropriate for others.
dx.doi.org/10.1001/jama.2026…
This grant helped me tremendously jumpstart the research I wanted to do. I encourage all those who are eligible to apply.
Are you an early-career investigator focused on #KidneyCancer research?
The Academy of Kidney Cancer Investigators – Early-Career Scholar Award supports innovative research while connecting scholars with experienced mentors and a national network of kidney cancer investigators.
Learn more and apply:
cdmrp.health.mil/funding/kcr…
#AcceleratingCures #KCRP
Maxine Sun retweeted
We would like to inform you that your post has been published on OncoDaily. Thank you for sharing!
oncodaily.com/voices/maxine-…
KCRS felt extra special this year: my first conference as a PI representing MHI. Great to reconnect with friends and colleagues, learn from leaders in the field, and watch Toni be genuinely surprised by a very well-deserved award. #KCRS26
Maxine Sun retweeted
That’s a wrap: #KCRS2026. I am filled with gratitude and hope. Ten years ago, I never imagined I’d be here, living with Stage IV kidney cancer, surrounded by so many brilliant people who have dedicated their lives to giving patients like me a future.
Thank you, @KidneyCAN, for your relentless leadership in bringing together patients, caregivers, researchers, clinicians, industry, and advocates to challenge the status quo and accelerate progress. Every breakthrough starts with people willing to work together.
For patients like me, KCRS isn’t just another conference. It’s a true reminder that hope is real, progress is happening, and we’re not done yet. Thank you to everyone helping turn a diagnosis into more tomorrows. The race is far from over. Let’s GO!! 👊👊❤️☘️
Maxine Sun retweeted
@PavlosMsaouel @MDAndersonnews puts his passion and life work behind extending survival for #renalmedullary cancers. Congrats on launching the newest IIT w a trop2 ADC for RMC!
Maxine Sun retweeted
Delighted to see the first brain metastases session in RCC at #KCRS26
The idea came to me from caring for patients with these complications on the oncology wards.
Grateful to have helped bring this session together, and hoping it ultimately benefits our patients.
Maxine Sun retweeted
10 years of @kidneycan !
Cannot wait to hear what each person in the room is doing to change the status quo
#AcceleratingCures #KCRS26
@OncoAlert
Maxine Sun retweeted
Predicting a person's health and disease arc many years in advance from their electronic health records and polygenic risk scores, along with the biological mechanism for the diseases
just published @Nature
Will be discussing the paper with the brilliant lead author @tigerstatdoc this Friday in Ground Truths 10:30 AM PST
nature.com/articles/s41586-0…
Maxine Sun retweeted
1/ Results from #ARC20 trial are out in @Nature!
This trial evaluated the HIF-2α inhibitor Casdatifan in heavily pretreated advanced ccRCC and provides important insights into HIF-2α biology and response. This is the 2nd HIF2 inhibitor with enough activity to move to a pivotal study after Belzutifan, cementing the 2019 @nobelprize story with @kaelinlab et al
Check it out: nature.com/articles/s41586-0…
Maxine Sun retweeted
Thanks to all who advocated to restore federal Kidney Cancer Research Program (KCRP) funding for FY26 - $15M is available NOW for research proposals! 🧡
🌟 Concept Award
🌟 AKCI Early-Career Scholar Award
🌟 Idea Development Award
Apply 🔗 cdmrp.health.mil/funding/kcr…
Maxine Sun retweeted
Please watch this 6 min of pure Gold to understand why ⚽️ is simply called “the Beautiful Game”
@Cristiano @KMbappe @erling @vinijr @VirgilvDijk @B_Fernandes8 @KingJames @KimKardashian @TedLasso @didierdrogba @itsyoungmiko @Ibra_official @10Ronaldinho @CANTONA_276 @channingtatum @tyler_adams14
I look forward to attending this and learn from the best! ⭐️
KidneyCAN is excited to share that we've made more room for you at #KCRS26!
In-person registration is available by request. Come join the world's leading #kidneycancer researchers as we connect and collaborate!
Can't get to Boston in July? We've saved you a free, virtual seat.
Register: bit.ly/KCRS26Registration
Maxine Sun retweeted
KidneyCAN is excited to share that we've made more room for you at #KCRS26!
In-person registration is available by request. Come join the world's leading #kidneycancer researchers as we connect and collaborate!
Can't get to Boston in July? We've saved you a free, virtual seat.
Register: bit.ly/KCRS26Registration